Daptomycin in the Treatment of Catheter-Related Staphylococcus Aureus
Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
Primary Objective:
Evaluate the efficacy and safety of daptomycin given for treatment of catheter-related
bloodstream infections due to S. aureus bacteria with or without exchange of the central
venous catheter (CVC) over guide wire in comparison with a historical control group of
catheter-related S. aureus bacteremia treated with standard therapy (Vancomycin) or other
active agents against staph aureus (such as beta-lactam antibiotics).